A Randomized, Open-label, Single Dose, Crossover, Phase Ⅰ Trial to Evaluate the Effect of Food on the Pharmacokinetics of LCB01-0371 in Healthy Male Subjects

Trial Profile

A Randomized, Open-label, Single Dose, Crossover, Phase Ⅰ Trial to Evaluate the Effect of Food on the Pharmacokinetics of LCB01-0371 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs LCB01-0371 (Primary)
  • Indications Bacterial infections; Gram-positive infections
  • Focus Adverse reactions
  • Sponsors LegoChem Biosciences
  • Most Recent Events

    • 18 Mar 2017 Data from this trial was used in physiologically based pharmacokinetic modelling to predict the food effect on the PK of LCB01-0371 and compared to the observations from the clinical study; outcomes presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 22 Mar 2016 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
    • 04 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top